Logo image of 1MSTR.MI

MICROSTRATEGY INC-CL A (1MSTR.MI) Stock Fundamental Analysis

BIT:1MSTR - Borsa Italiana Milan - US5949724083 - Common Stock - Currency: EUR

334.7  +11.8 (+3.65%)

Fundamental Rating

1

Overall 1MSTR gets a fundamental rating of 1 out of 10. We evaluated 1MSTR against 98 industry peers in the Software industry. 1MSTR may be in some trouble as it scores bad on both profitability and health. 1MSTR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

1MSTR had negative earnings in the past year.
1MSTR had a negative operating cash flow in the past year.
In multiple years 1MSTR reported negative net income over the last 5 years.
1MSTR had a positive operating cash flow in each of the past 5 years.
1MSTR.MI Yearly Net Income VS EBIT VS OCF VS FCF1MSTR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

1MSTR's Return On Assets of -4.87% is on the low side compared to the rest of the industry. 1MSTR is outperformed by 70.11% of its industry peers.
The Return On Equity of 1MSTR (-10.78%) is worse than 70.11% of its industry peers.
Industry RankSector Rank
ROA -4.87%
ROE -10.78%
ROIC N/A
ROA(3y)-22.34%
ROA(5y)-12.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1MSTR.MI Yearly ROA, ROE, ROIC1MSTR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

In the last couple of years the Profit Margin of 1MSTR has grown nicely.
In the last couple of years the Operating Margin of 1MSTR has declined.
Looking at the Gross Margin, with a value of 73.56%, 1MSTR is in line with its industry, outperforming 51.72% of the companies in the same industry.
1MSTR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for 1MSTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.56%
OM growth 3Y-76.1%
OM growth 5Y-27.34%
PM growth 3YN/A
PM growth 5Y80.43%
GM growth 3Y-1.34%
GM growth 5Y-0.55%
1MSTR.MI Yearly Profit, Operating, Gross Margins1MSTR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

2

2. Health

2.1 Basic Checks

1MSTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1MSTR has been increased compared to 1 year ago.
1MSTR has more shares outstanding than it did 5 years ago.
1MSTR has a better debt/assets ratio than last year.
1MSTR.MI Yearly Shares Outstanding1MSTR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M
1MSTR.MI Yearly Total Debt VS Total Assets1MSTR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 10.89 indicates that 1MSTR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.89, 1MSTR belongs to the top of the industry, outperforming 87.36% of the companies in the same industry.
1MSTR has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.12, 1MSTR is doing worse than 86.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Altman-Z 10.89
ROIC/WACCN/A
WACC10.82%
1MSTR.MI Yearly LT Debt VS Equity VS FCF1MSTR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B -2B

2.3 Liquidity

A Current Ratio of 0.65 indicates that 1MSTR may have some problems paying its short term obligations.
1MSTR has a Current ratio of 0.65. This is amonst the worse of the industry: 1MSTR underperforms 93.10% of its industry peers.
1MSTR has a Quick Ratio of 0.65. This is a bad value and indicates that 1MSTR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.65, 1MSTR is doing worse than 91.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.65
1MSTR.MI Yearly Current Assets VS Current Liabilites1MSTR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

0

3. Growth

3.1 Past

The earnings per share for 1MSTR have decreased strongly by -1360.10% in the last year.
Measured over the past years, 1MSTR shows a very strong growth in Earnings Per Share. The EPS has been growing by 77.06% on average per year.
1MSTR shows a decrease in Revenue. In the last year, the revenue decreased by -7.35%.
The Revenue has been decreasing by -0.06% on average over the past years.
EPS 1Y (TTM)-1360.1%
EPS 3Y95.98%
EPS 5Y77.06%
EPS Q2Q%-91.54%
Revenue 1Y (TTM)-7.35%
Revenue growth 3Y1.07%
Revenue growth 5Y-0.06%
Sales Q2Q%-10.34%

3.2 Future

1MSTR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -27.83% yearly.
The Revenue is expected to decrease by -2.11% on average over the next years.
EPS Next Y-190.6%
EPS Next 2Y-46.37%
EPS Next 3Y-27.83%
EPS Next 5YN/A
Revenue Next Year-6.93%
Revenue Next 2Y-2.44%
Revenue Next 3Y0.57%
Revenue Next 5Y-2.11%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1MSTR.MI Yearly Revenue VS Estimates1MSTR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
1MSTR.MI Yearly EPS VS Estimates1MSTR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -5 -10

0

4. Valuation

4.1 Price/Earnings Ratio

1MSTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year 1MSTR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1MSTR.MI Price Earnings VS Forward Price Earnings1MSTR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1MSTR.MI Per share data1MSTR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

1MSTR's earnings are expected to decrease with -27.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.37%
EPS Next 3Y-27.83%

0

5. Dividend

5.1 Amount

1MSTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MICROSTRATEGY INC-CL A

BIT:1MSTR (2/4/2025, 7:00:00 PM)

334.7

+11.8 (+3.65%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners50.47%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap81.95B
Analysts84
Price Target405.15 (21.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-752.6%
Min EPS beat(2)-1095.94%
Max EPS beat(2)-409.27%
EPS beat(4)1
Avg EPS beat(4)-780.19%
Min EPS beat(4)-2517.33%
Max EPS beat(4)901.78%
EPS beat(8)3
Avg EPS beat(8)-13638.8%
EPS beat(12)4
Avg EPS beat(12)-9319.26%
EPS beat(16)7
Avg EPS beat(16)-6975.79%
Revenue beat(2)0
Avg Revenue beat(2)-9.05%
Min Revenue beat(2)-10.88%
Max Revenue beat(2)-7.22%
Revenue beat(4)0
Avg Revenue beat(4)-8.36%
Min Revenue beat(4)-10.88%
Max Revenue beat(4)-7.18%
Revenue beat(8)2
Avg Revenue beat(8)-4.85%
Revenue beat(12)2
Avg Revenue beat(12)-4.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 181.28
P/FCF N/A
P/OCF N/A
P/B 22.45
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.48
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-20.79
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS1.85
BVpS14.91
TBVpS-12.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.87%
ROE -10.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.56%
FCFM N/A
ROA(3y)-22.34%
ROA(5y)-12.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)0.65%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-76.1%
OM growth 5Y-27.34%
PM growth 3YN/A
PM growth 5Y80.43%
GM growth 3Y-1.34%
GM growth 5Y-0.55%
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29355.6%
Cap/Sales 1118.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.65
Altman-Z 10.89
F-Score2
WACC10.82%
ROIC/WACCN/A
Cap/Depr(3y)12978.2%
Cap/Depr(5y)9492.25%
Cap/Sales(3y)318.95%
Cap/Sales(5y)238.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1360.1%
EPS 3Y95.98%
EPS 5Y77.06%
EPS Q2Q%-91.54%
EPS Next Y-190.6%
EPS Next 2Y-46.37%
EPS Next 3Y-27.83%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.35%
Revenue growth 3Y1.07%
Revenue growth 5Y-0.06%
Sales Q2Q%-10.34%
Revenue Next Year-6.93%
Revenue Next 2Y-2.44%
Revenue Next 3Y0.57%
Revenue Next 5Y-2.11%
EBIT growth 1Y-781.24%
EBIT growth 3Y-75.85%
EBIT growth 5Y-27.38%
EBIT Next Year-56.52%
EBIT Next 3Y-5.27%
EBIT Next 5YN/A
FCF growth 1Y-557.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-240.02%
OCF growth 3Y-38.11%
OCF growth 5Y3.65%